Items Tagged ‘breakthrough status’

May 23rd, 2016

Genetically Modified Poliovirus Granted “Breakthrough” by FDA for Glioblastoma


The United States Food and Drug Administration (FDA) has granted “breakthrough status” designation for the treatment of glioblastoma containing a genetically modified poliovirus. Glioblastoma is an extremely aggressive form of brain cancer, with few patients surviving 5 years following diagnosis. Despite efforts with surgery, chemotherapy, and/or radiation therapy, the overall outcomes for patients with glioblastoma […]

View full entry

Tags: Brain Cancer, breakthrough status, fda, General Brain Cancer, genetically modified polio virus, glioblastoma, immunotherapy, News